What a surprise -- FDA is corrupt. Seems that they
Post# of 72440
Quote:
In addition to McKinsey’s opioids work, according to documents obtained by the House committee in its drug pricing investigation, McKinsey in August 2010 also advised AbbVie on ways to block competition for its blockbuster drug, Humira, which will remain without biosimilar competition until 2023. McKinsey was working closely with the FDA’s generic drug office at the time, the committee said.
https://endpts.com/house-oversight-committee-...mpetitors/
So tell me again: no organized groups have gone after IPIX, there are no multiple identity bashers involved with organized groups, all of the shorting is perfectly legal, and the FDA asking for an absurdly large and expensive clinical trial for the ABSSSI indication has NOTHING to do with how it would hurt Daptomycin sales and help IPIX become a major company. Nope, FDA and shorts would NEVER EVER do anything like that.